切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - 5-HT7 Receptors - IRAK - GLI - Deubiquitinating enzymes (DUBs)

14件产品中的 1-10

页面
每页
清除全部
  1. Spautin-1
    B5873 Spautin-1
     1 Citation
    Target: Deubiquitinating enzymes (DUBs)|Autophagy
    Summary: 自噬抑制剂
      ≥13.5 mg/mL
      insoluble in H2O
  2. Lurasidone HCl
    B1477 Lurasidone HCl
    中文名: 盐酸鲁拉西酮
    Target: 5-HT2 Receptors|D2 Receptors|5-HT1 Receptors|5-HT7 Receptors
    Summary: 多巴胺D2/5-HT2A/5-HT7/5-HT1A抑制剂
      ≥11.11 mg/mL
      insoluble in H2O
  3. Quetiapine Fumarate
    B1490 Quetiapine Fumarate
     1 Citation
    中文名: 富马酸奎硫平
    Target: 5-HT2 Receptors|D1 and D5 Receptors|D2 Receptors|D3 Receptors|5-HT1 Receptors|5-HT7 Receptors
    Summary: 多巴胺受体拮抗剂
      ≥11.03 mg/mL
      insoluble in H2O
  4. ML-323
    B1317 ML-323
    Target: Deubiquitinating enzymes (DUBs)
    Summary: USP1-UAF1抑制剂
      ≥15.05 mg/mL
      ≥2.25 mg/mL
  5. GANT61
    A1615 GANT61
     1 Citation
    Target: GLI
    Summary: GLI拮抗剂
      insoluble in DMSO
      insoluble in H2O
  6. PR-619
    A8212 PR-619
    Target: Deubiquitinating enzymes (DUBs)
    Summary: 去泛素化酶(DUBs)抑制剂
      ≥11.15 mg/mL
      insoluble in H2O
  7. NSC 687852 (b-AP15)
    A4453 NSC 687852 (b-AP15)
    Target: Deubiquitinating enzymes (DUBs)
    Summary: 19S调节颗粒抑制剂
      ≥20.95 mg/mL
      insoluble in H2O
  8. Vialinin A
    A4429 Vialinin A
    Target: Deubiquitinating enzymes (DUBs)|IL Receptors|CCL2
    Summary: USP/IsoT/UCH-L1 DUB抑制剂
      Soluble in DMSO
  9. Vortioxetine
    A3926 Vortioxetine
    中文名: 沃替西汀
    Target: 5-HT1 Receptors|5-HT7 Receptors|5-HT3 Receptors|SERT
    Summary: 5-HT受体拮抗剂
      ≥14.92 mg/mL
      insoluble in H2O
  10. IRAK-1-4 Inhibitor I
    A3505 IRAK-1-4 Inhibitor I
     3 Citation
    Target: IRAK
    Summary: IRAK-1/4抑制剂
      ≥19.75 mg/mL
      insoluble in H2O

14件产品中的 1-10

页面
每页